PortalPublikationenIs the Munich dysphagia Test–Parkinson's disease (MDT-PD) a ...

Is the Munich dysphagia Test–Parkinson's disease (MDT-PD) a Valid screening tool for patients at risk for aspiration?

Standard

Is the Munich dysphagia Test–Parkinson's disease (MDT-PD) a Valid screening tool for patients at risk for aspiration? / Buhmann, Carsten; Flügel, Till; Bihler, Moritz; Gerloff, Christian; Nießen, Almut; Hidding, Ute; Nienstedt, Julie Cläre; Pflug, Christina.

in: PARKINSONISM RELAT D, Jahrgang 61, 04.2019, S. 138-143.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Buhmann, C, Flügel, T, Bihler, M, Gerloff, C, Nießen, A, Hidding, U, Nienstedt, JC & Pflug, C 2019, 'Is the Munich dysphagia Test–Parkinson's disease (MDT-PD) a Valid screening tool for patients at risk for aspiration?', PARKINSONISM RELAT D, Jg. 61, S. 138-143. https://doi.org/10.1016/j.parkreldis.2018.10.031

APA

Buhmann, C., Flügel, T., Bihler, M., Gerloff, C., Nießen, A., Hidding, U., Nienstedt, J. C., & Pflug, C. (2019). Is the Munich dysphagia Test–Parkinson's disease (MDT-PD) a Valid screening tool for patients at risk for aspiration? PARKINSONISM RELAT D, 61, 138-143. https://doi.org/10.1016/j.parkreldis.2018.10.031

Vancouver

Buhmann C, Flügel T, Bihler M, Gerloff C, Nießen A, Hidding U et al. Is the Munich dysphagia Test–Parkinson's disease (MDT-PD) a Valid screening tool for patients at risk for aspiration? PARKINSONISM RELAT D. 2019 Apr;61:138-143. https://doi.org/10.1016/j.parkreldis.2018.10.031

Bibtex

@article{c2cb6fba70d64f95a7a2f794be7431cf,
title = "Is the Munich dysphagia Test–Parkinson's disease (MDT-PD) a Valid screening tool for patients at risk for aspiration?",
abstract = "BackgroundDysphagia is common in Parkinson's disease (PD) and leads to pneumonia, malnutrition, and reduced quality of life. For detecting dysphagia-exposed PD patients, the Munich dysphagia test–Parkinson's disease (MDT-PD) is a patient self-reported tool that has been developed specifically for PD patients. The MDT-PD is available in both German and English. This study aimed to ascertain whether the MDT-PD can detect aspiration in PD patients and, therefore, serve as a suitable screening tool.MethodsIn a controlled, cross-sectional, observational study, a total of 119 PD outpatients were examined clinically and were evaluated by the MDT-PD and the one swallowing question (NMS-3) from the nonmotor symptom questionnaire for Parkinson's disease (NMSQuest). The results of the MDT-PD and the NMS-3 were compared to the penetration-aspiration scale (PAS) rating defined by flexible endoscopic evaluation of swallowing (FEES).Key resultsHalf of the patients with aspiration as determined using FEES were not detected by the MDT-PD and NMS-3 self-reported tools. The proportion of false positive patients was high with both tools. The sensitivity of the MDT-PD to detect patients who are at risk for aspiration is insufficient (0.37) and not superior to applying the dysphagia screening question from the NMSQuest (0.5).ConclusionThis study reveals that the MDT-PD is not suitable for detecting aspiration in PD patients and, therefore, cannot be considered as a screening tool for aspiration. However, at present, there is no alternative validated screening tool that can reliably detect aspiration in PD patients. A readjustment of the MDT-PD is urgently needed.",
author = "Carsten Buhmann and Till Fl{\"u}gel and Moritz Bihler and Christian Gerloff and Almut Nie{\ss}en and Ute Hidding and Nienstedt, {Julie Cl{\"a}re} and Christina Pflug",
note = "Copyright {\textcopyright} 2018 Elsevier Ltd. All rights reserved.",
year = "2019",
month = apr,
doi = "10.1016/j.parkreldis.2018.10.031",
language = "English",
volume = "61",
pages = "138--143",
journal = "PARKINSONISM RELAT D",
issn = "1353-8020",
publisher = "Elsevier BV",

}

RIS

TY - JOUR

T1 - Is the Munich dysphagia Test–Parkinson's disease (MDT-PD) a Valid screening tool for patients at risk for aspiration?

AU - Buhmann, Carsten

AU - Flügel, Till

AU - Bihler, Moritz

AU - Gerloff, Christian

AU - Nießen, Almut

AU - Hidding, Ute

AU - Nienstedt, Julie Cläre

AU - Pflug, Christina

N1 - Copyright © 2018 Elsevier Ltd. All rights reserved.

PY - 2019/4

Y1 - 2019/4

N2 - BackgroundDysphagia is common in Parkinson's disease (PD) and leads to pneumonia, malnutrition, and reduced quality of life. For detecting dysphagia-exposed PD patients, the Munich dysphagia test–Parkinson's disease (MDT-PD) is a patient self-reported tool that has been developed specifically for PD patients. The MDT-PD is available in both German and English. This study aimed to ascertain whether the MDT-PD can detect aspiration in PD patients and, therefore, serve as a suitable screening tool.MethodsIn a controlled, cross-sectional, observational study, a total of 119 PD outpatients were examined clinically and were evaluated by the MDT-PD and the one swallowing question (NMS-3) from the nonmotor symptom questionnaire for Parkinson's disease (NMSQuest). The results of the MDT-PD and the NMS-3 were compared to the penetration-aspiration scale (PAS) rating defined by flexible endoscopic evaluation of swallowing (FEES).Key resultsHalf of the patients with aspiration as determined using FEES were not detected by the MDT-PD and NMS-3 self-reported tools. The proportion of false positive patients was high with both tools. The sensitivity of the MDT-PD to detect patients who are at risk for aspiration is insufficient (0.37) and not superior to applying the dysphagia screening question from the NMSQuest (0.5).ConclusionThis study reveals that the MDT-PD is not suitable for detecting aspiration in PD patients and, therefore, cannot be considered as a screening tool for aspiration. However, at present, there is no alternative validated screening tool that can reliably detect aspiration in PD patients. A readjustment of the MDT-PD is urgently needed.

AB - BackgroundDysphagia is common in Parkinson's disease (PD) and leads to pneumonia, malnutrition, and reduced quality of life. For detecting dysphagia-exposed PD patients, the Munich dysphagia test–Parkinson's disease (MDT-PD) is a patient self-reported tool that has been developed specifically for PD patients. The MDT-PD is available in both German and English. This study aimed to ascertain whether the MDT-PD can detect aspiration in PD patients and, therefore, serve as a suitable screening tool.MethodsIn a controlled, cross-sectional, observational study, a total of 119 PD outpatients were examined clinically and were evaluated by the MDT-PD and the one swallowing question (NMS-3) from the nonmotor symptom questionnaire for Parkinson's disease (NMSQuest). The results of the MDT-PD and the NMS-3 were compared to the penetration-aspiration scale (PAS) rating defined by flexible endoscopic evaluation of swallowing (FEES).Key resultsHalf of the patients with aspiration as determined using FEES were not detected by the MDT-PD and NMS-3 self-reported tools. The proportion of false positive patients was high with both tools. The sensitivity of the MDT-PD to detect patients who are at risk for aspiration is insufficient (0.37) and not superior to applying the dysphagia screening question from the NMSQuest (0.5).ConclusionThis study reveals that the MDT-PD is not suitable for detecting aspiration in PD patients and, therefore, cannot be considered as a screening tool for aspiration. However, at present, there is no alternative validated screening tool that can reliably detect aspiration in PD patients. A readjustment of the MDT-PD is urgently needed.

UR - https://doi.org/10.1016/j.parkreldis.2018.10.031

U2 - 10.1016/j.parkreldis.2018.10.031

DO - 10.1016/j.parkreldis.2018.10.031

M3 - SCORING: Journal article

C2 - 30414724

VL - 61

SP - 138

EP - 143

JO - PARKINSONISM RELAT D

JF - PARKINSONISM RELAT D

SN - 1353-8020

ER -